Standout Papers
Citation Impact
Citing Papers
Assembly of a Functional HCV Glycoprotein Heterodimer
2007
The Hepatitis C Virus NS2/3 Protease
2007
Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition
2016
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Compensatory Mutations in E1, p7, NS2, and NS3 Enhance Yields of Cell Culture-Infectious Intergenotypic Chimeric Hepatitis C Virus
2006
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
2020 StandoutScience
Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
2013 Science
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost
2006
Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations
2009
NS2 Protein of Hepatitis C Virus Interacts with Structural and Non-Structural Proteins towards Virus Assembly
2011
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction
2006
Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
2012
Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps
2012
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivity
2017
Hepatitis C Virus Genotype 1a Growth and Induction of Autophagy
2007
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles
2012
Early steps of the hepatitis C virus life cycle
2008
Assembly of infectious hepatitis C virus particles
2010
Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation
2012
Hepatitis C virus entry into host cells
2007
Intracellular Proton Conductance of the Hepatitis C Virus p7 Protein and Its Contribution to Infectious Virus Production
2010
Study of hepatitis C virus entry in genetically humanized mice
2012 StandoutNobel
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Development of novel therapies for hepatitis C
2010
Murine models of hepatitis C: What can we look forward to?
2014
Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B
2009
Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals
2012
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
2013 StandoutNatureNobel
Hepatitis C virus—host interactions, replication, and viral assembly
2012
Molecular Determinants and Dynamics of Hepatitis C Virus Secretion
2012
Epigallocatechin-3-Gallate (EGCG), a Green Tea Polyphenol, Stimulates Hepatic Autophagy and Lipid Clearance
2014
Turning Hepatitis C into a Real Virus
2010 StandoutNobel
Role of lipid metabolism in hepatitis C virus assembly and entry
2009
Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo
2008
Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A
2017
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis
2008 StandoutNobel
Surveying the global virome: Identification and characterization of HCV-related animal hepaciviruses
2014
Generation of a Cell Culture-Adapted Hepatitis C Virus with Longer Half Life at Physiological Temperature
2011
Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir
2016
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
2009
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
2014
Barriers of hepatitis C virus interspecies transmission
2012
Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion
2011
trans-Complementation of an NS2 Defect in a Late Step in Hepatitis C Virus (HCV) Particle Assembly and Maturation
2009
Hepatitis C virus entry: Molecular biology and clinical implications
2006
Hepatitis E virus persists in the presence of a type III interferon response
2017
Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles
2009
The past, present and future of neutralizing antibodies for hepatitis C virus
2014
New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets
2012
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
Intravascular Transfer Contributes to Postprandial Increase in Numbers of Very-Low-Density Hepatitis C Virus Particles
2010
Non-random Escape Pathways from a Broadly Neutralizing Human Monoclonal Antibody Map to a Highly Conserved Region on the Hepatitis C Virus E2 Glycoprotein Encompassing Amino Acids 412–423
2014
Hepatitis C Virus Proteins: From Structure to Function
2013
RNA Interference and Single Particle Tracking Analysis of Hepatitis C Virus Endocytosis
2009
The lipid droplet is an important organelle for hepatitis C virus production
2007
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
2007
A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
2011
Hepatitis C virus host cell entry
2012
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Mouse Hepatic Cells Support Assembly of Infectious Hepatitis C Virus Particles
2011
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Antiviral strategies in hepatitis C virus infection
2012
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
2014
A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach
2010
Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome
2010
Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
2010
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control
2016
Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein
2008
RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells
2010
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
2009 StandoutNatureNobel
Temporal Analysis of Hepatitis C Virus Cell Entry with Occludin Directed Blocking Antibodies
2013
Dissecting noncoding and pathogen RNA–protein interactomes
2014
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel
2008
Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry
2013
Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
2010
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Global control of hepatitis C: where challenge meets opportunity
2013
Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha
2013
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein
2013 StandoutNobel
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Analysis of Functional Differences between Hepatitis C Virus NS5A of Genotypes 1–7 in Infectious Cell Culture Systems
2012
Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs # †
2008
Hepatitis C Virus Entry
2007 StandoutNobel
Virion Assembly and Release
2013
The Lipid Droplet Binding Domain of Hepatitis C Virus Core Protein Is a Major Determinant for Efficient Virus Assembly
2007
Measuring HCV Infectivity Produced in Cell Culture and In Vivo
2009
Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes
2010
Diacylglycerol Acyltransferase-1 Localizes Hepatitis C Virus NS5A Protein to Lipid Droplets and Enhances NS5A Interaction with the Viral Capsid Core
2013
The Postbinding Activity of Scavenger Receptor Class B Type I Mediates Initiation of Hepatitis C Virus Infection and Viral Dissemination
2012
The Exchangeable Apolipoprotein ApoC-I Promotes Membrane Fusion of Hepatitis C Virus
2007
Animal Models for Hepatitis C
2013
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics
2010
Unusual architecture of the p7 channel from hepatitis C virus
2013 Nature
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment
2009
Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture
2006
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells
2017
A Concerted Action of Hepatitis C Virus P7 and Nonstructural Protein 2 Regulates Core Localization at the Endoplasmic Reticulum and Virus Assembly
2011
Hepatic Cells Derived From Induced Pluripotent Stem Cells of Pigtail Macaques Support Hepatitis C Virus Infection
2013
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
2010
Recombinant HCV Variants With NS5A From Genotypes 1–7 Have Different Sensitivities to an NS5A Inhibitor but Not Interferon-α
2010
Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation
2011
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity
2016
Differential Sensitivity of Bat Cells to Infection by Enveloped RNA Viruses: Coronaviruses, Paramyxoviruses, Filoviruses, and Influenza Viruses
2013
Apolipoprotein E Interacts With Hepatitis C Virus Nonstructural Protein 5A and Determines Assembly of Infectious Particles
2009
A Cell Culture Adapted HCV JFH1 Variant That Increases Viral Titers and Permits the Production of High Titer Infectious Chimeric Reporter Viruses
2012
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly
2010
Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication
2012
Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly
2008
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
2010 Nature
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy
2010
Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E Virus
2014
How hepatitis C virus invades hepatocytes: The mystery of viral entry
2014
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
2015
Regulation of the Production of Infectious Genotype 1a Hepatitis C Virus by NS5A Domain III
2011
The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy
2009
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
2003 StandoutNobel
The NS3 Helicase and NS5B-to-3′X Regions Are Important for Efficient Hepatitis C Virus Strain JFH-1 Replication in Huh7 Cells
2007
Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion
2007
Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells
2012
Hepatitis C virus: viral proteins on the move
2009
The hepatitis C virus NS2/3 protease.
2007
Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus
2008
Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus
2012
Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes
2007
A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I
2016
Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly
2009
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Characterization of the Envelope Glycoproteins Associated with Infectious Hepatitis C Virus
2010
Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells
2007
Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection
2009
Novel Mutations in a Tissue Culture-Adapted Hepatitis C Virus Strain Improve Infectious-Virus Stability and Markedly Enhance Infection Kinetics
2011
Hepatitis C Virus Entry
2013
Role of Annexin A2 in the Production of Infectious Hepatitis C Virus Particles
2010
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity
2007
Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains
2012
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Determinants of the Hepatitis C Virus Nonstructural Protein 2 Protease Domain Required for Production of Infectious Virus
2009 StandoutNobel
Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant
2007
Hepatitis C virus cell entry: role of lipoproteins and cellular receptors
2009
Role of Hypervariable Region 1 for the Interplay of Hepatitis C Virus with Entry Factors and Lipoproteins
2014
Antiviral Stilbene 1,2-Diamines Prevent Initiation of Hepatitis C Virus RNA Replication at the Outset of Infection
2011 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization
2008
Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures
2007
Identification of transferrin receptor 1 as a hepatitis C virus entry factor
2013
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
2015
Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method To Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes from HCV Genotypes 1 to 6
2010
The Strange, Expanding World of Animal Hepaciviruses
2016
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Hepatitis C Virus NS2 Protein Serves as a Scaffold for Virus Assembly by Interacting with both Structural and Nonstructural Proteins
2010
Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction
2014 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Hepatitis C Virus NS2 Protein Contributes to Virus Particle Assembly via Opposing Epistatic Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes
2009
Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles
2008
Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus
2007 StandoutNobel
Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity
2016
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes
2008
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Blocking HCV Entry as Potential Antiviral Therapy
2012
Cellular cofactors affecting hepatitis C virus infection and replication
2007 StandoutNobel
Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus
2016
Hypervariable Region 1 Deletion and Required Adaptive Envelope Mutations Confer Decreased Dependency on Scavenger Receptor Class B Type I and Low-Density Lipoprotein Receptor for Hepatitis C Virus
2013
Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
2011
The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection
2009
The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus
2008
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells
2019 StandoutNobel
Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system
2012
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
2010 StandoutNobel
Neutralizing Antibody Response to Hepatitis C Virus
2011
Development and Application of Hepatitis C Reporter Viruses with Genotype 1 to 7 Core-Nonstructural Protein 2 (NS2) Expressing Fluorescent Proteins or Luciferase in Modified JFH1 NS5A
2011
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Virus‐neutralizing antibodies to hepatitis C virus
2013
Novel Infectious cDNA Clones of Hepatitis C Virus Genotype 3a (Strain S52) and 4a (Strain ED43): Genetic Analyses and In Vivo Pathogenesis Studies
2010
Hepatitis C Virus NS2 Coordinates Virus Particle Assembly through Physical Interactions with the E1-E2 Glycoprotein and NS3-NS4A Enzyme Complexes
2010
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein
2013 StandoutNobel
Cyclophilin A Interacts with Domain II of Hepatitis C Virus NS5A and Stimulates RNA Binding in an Isomerase-Dependent Manner
2011
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
The Hepatitis C Virus NS4B Protein Can trans -Complement Viral RNA Replication and Modulates Production of Infectious Virus
2008
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Characterization of Hepatitis C Virus Interaction with Heparan Sulfate Proteoglycans
2015
NS3 Helicase Domains Involved in Infectious Intracellular Hepatitis C Virus Particle Assembly
2008
Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture
2010
Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles
2006
The Acidic Domain of Hepatitis C Virus NS4A Contributes to RNA Replication and Virus Particle Assembly
2010
The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells
2006
Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry
2012
In vivo models of hepatitis B and C virus infection
2016
Airborne transmission of respiratory viruses
2021 StandoutScience
Cell Culture-Adaptive Mutations Promote Viral Protein-Protein Interactions and Morphogenesis of Infectious Hepatitis C Virus
2012
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations
2019
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
Genetic Dissection of the Host Tropism of Human-Tropic Pathogens
2015
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Targeting HCV Entry For Development of Therapeutics
2010
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Eike Steinmann being referenced
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
2006
How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV and Its Susceptibility to Chemical Biocides
2010
Cell Culture Systems for Hepatitis C Virus
2013
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
2010
Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment
2012
Specific Acquisition of Functional CD59 but Not CD46 or CD55 by Hepatitis C Virus
2012
Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment
2013
Frequent presence of hepaci and pegiviruses in commercial equine serum pools
2015
Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay
2009
Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration
2010
Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell Lines
2011
Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus
2010
Structural and Functional Characterization of Nonstructural Protein 2 for Its Role in Hepatitis C Virus Assembly
2008
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
2020 Standout
Hepatitis C Virus Replication in Mouse Cells Is Restricted by IFN-Dependent and -Independent Mechanisms
2013
Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions
2007
Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication
2012
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A #
2009
NMR Structure and Ion Channel Activity of the p7 Protein from Hepatitis C Virus
2010
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus†
2007
Susceptibility of SARS-CoV-2 to UV irradiation
2020
The impact of hepatitis E in the liver transplant setting
2014
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
2016
Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes
2005
Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission
2016
Hepatitis C Virus P7—A Viroporin Crucial for Virus Assembly and an Emerging Target for Antiviral Therapy
2010
Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design
2015
Natural reservoirs for homologs of hepatitis C virus
2014
Efficienttrans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles
2008
Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans -Complementation
2009
Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication
2016
Clinical course of infection and viral tissue tropism of hepatitis C virus–like nonprimate hepaciviruses in horses
2014
Subcellular Localization and Function of an Epitope-Tagged p7 Viroporin in Hepatitis C Virus-Producing Cells
2012
Characterization of Hepatitis C Virus Intra- and Intergenotypic Chimeras Reveals a Role of the Glycoproteins in Virus Envelopment
2013
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses
2006
Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes
2010
Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure
2015
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel